Page last updated: 2024-10-29

whi p154 and Cancer of Lung

whi p154 has been researched along with Cancer of Lung in 2 studies

WHI P154: an anti-leukemic agent; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, H1
Zhang, YK1
Wang, YJ1
Kathawala, RJ1
Patel, A1
Zhu, H1
Sodani, K1
Talele, TT1
Ambudkar, SV1
Chen, ZS1
Fu, LW1
Wang, YW1
Tu, PH1
Lin, KT1
Lin, SC1
Ko, JY1
Jou, YS1

Other Studies

2 other studies available for whi p154 and Cancer of Lung

ArticleYear
WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells.
    Cancer science, 2014, Volume: 105, Issue:8

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette

2014
Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer.
    Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Anaplastic Lymphoma Kinase; Animals; Biomarkers

2011
chemdatabank.com